Preview

Cardiovascular Therapy and Prevention

Advanced search

Prevalence of carotid and femoral artery atherosclerosis among the Ivanovo Oblast population: data from the ATEROGEN-Ivanovo study

https://doi.org/10.15829/1728-8800-2021-2994

Abstract

Aim. To study the prevalence of carotid (CA) and femoral artery (FA) atherosclerosis among Russian population, mainly in middle age group, using a representative sample of one of the Central Russian regions.

Material and methods. The analysis included participants of the ATEROGEN-Ivanovo study (sub-study of the ESSE-RF conducted in the Ivanovo region) aged 40-67 years, who were invited for CA and FA ultrasound to assess plaque presence. A total 1102 people were examined, which was >80% of the original sample.

Results. The age of subjects was 54 [48; 60] years (men, 28%). Only 11,2% of participants took statins; 30,9% had low cardiovascular risk (CVR), 35,6% — moderate CVR, 21,8% — high CVR, and 11,8% — very high CVR. The incidence of at least one plaque in CA or FA was 73,6%. The prevalence of CA atherosclerosis was 76,4% in men and 59,1% in women, FA atherosclerosis — 54,9% and 28,3%, respectively. Furthermore, plaques were detected already at the age of 40. The incidence of plaques significantly increased with age, with the exception of carotid atherosclerosis in men, a significant increase in the incidence of which stopped at 45 years of age.

Conclusion. Among the Ivanovo population aged 40-67 with a predominance of low-to-moderate CVR patients, there is a high prevalence of carotid and femoral atherosclerosis, which indicates a high potential for using ultrasound for diagnosing subclinical atherosclerosis in assessing CVR in people of this age range.

About the Authors

A. I. Ershova
National Medical Research Center of Cardiology; Moscow State University of Medicine and Dentistry
Russian Federation

Moscow.

Tel.: +7 (916) 559-85-36



T. V. Balakhonova
National Medical Research Center of Cardiology; I.M. Sechenov First Moscow State Medical University
Russian Federation

Moscow.



A. N. Meshkov
National Medical Research Center of Cardiology; Moscow State University of Medicine and Dentistry
Russian Federation

Moscow.



V. A. Kutsenko
National Medical Research Center of Cardiology; Moscow State University of Medicine and Dentistry
Russian Federation

Moscow.



E. B. Yarovaya
National Medical Research Center of Cardiology; Moscow State University of Medicine and Dentistry
Russian Federation

Moscow.



S. A. Shalnova
National Medical Research Center of Cardiology; Moscow State University of Medicine and Dentistry
Russian Federation

Moscow.



N. E. Lishchenko
Cardiology dispensary
Russian Federation

Ivanovo.



A. S. Novikova
Cardiology dispensary
Russian Federation

Ivanovo.



E. L. Aleksandrova
Cardiology dispensary
Russian Federation

Ivanovo.



E. A. Shutemova
Cardiology dispensary
Russian Federation

Ivanovo.



O. A. Belova
Cardiology dispensary
Russian Federation

Ivanovo.



S. A. Rachkova
Cardiology dispensary
Russian Federation

Ivanovo.



S. A. Boytsov
National Medical Research Center of Cardiology; Moscow State University of Medicine and Dentistry
Russian Federation

Moscow.



O. M. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation

Moscow.



References

1. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.

2. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat of atherosclerosis Russian recommendations VII revision. Atherosclerosis and dyslipidemia. 2020;1(38):7-42. (In Russ.)

3. Thorsson B, Eiriksdottir G, Sigurdsson S, et al. Population distribution of traditional and the emerging cardiovascular risk factors carotid plaque and IMT: the REFINE-Reykjavik study with comparison with the Troms0 study. BMJ Open. 2018;8(5):e019385. doi:10.1136/bmjopen-2017-019385.

4. Meshkov AN, Boitsov SA, Ershova AI, et al. The ATHEROGEN-IVANOVO trial “Investigation of the specific features of the development and progression of ATHEROsclerosis at various sites, including those with a view to the GENetic and epigenetic cardiovascular risk factors — the ESSE-IVANOVO substudy” — design, bioinformation analysis algorithms, and exome sequencing results in pilot group patients. Profilakticheskaya Meditsina. 2013;16(6):11-20. (In Russ.)

5. Research organizing committee of the ESSE-RF project. Epidemiology of cardiovascular diseases in different regions of Russia (ESSE-RF). The rationale for and design of the study. Preventive medicine. 2013;16(6):25-34. (In Russ.)

6. Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-20062011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6. doi:10.1159/000343145.

7. Gostomzyk JG, Heller WD, Gerhardt P, et al. B-scan ultrasound examination of the carotid arteries within a representative population (MONICA Project Augsburg). Klin Wochenschr. 1988;66 Suppl 11:58-65.

8. Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23(12):1705-11. doi:10.1161/01.str.23.12.1705.

9. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis. A population-based study. Arterioscler Thromb. 1993;13(5):661-8. doi:10.1161/01.atv.13.5.661.

10. Li R, Duncan BB, Metcalf PA, et al. B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;25(12):2377-83. doi:10.1161/01.str.25.12.2377.

11. Joakimsen O, Bonaa KH, Stensland-Bugge E, et al. Age and sex differences in the distribution and ultrasound morphology of carotid atherosclerosis: The Troms0 Study. Arterioscler Thromb Vasc Biol. 1999;19(12):3007-13. doi:10.1161/01.atv.19.12.3007.

12. Mannami T, Konishi M, Baba S, et al. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: The Suita study. Stroke. 1997;28(3):518-25. doi:10.1161/01.str.28.3.518.

13. Leng GC, Papacosta O, Whincup P, et al. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis. 2000;152(1):167-74. doi:10.1016/s0021-9150(99)00447-5.

14. Zhernakova YV, Kaveshnikov VS, Serebriakova VN, et al. The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk. Systemic Hypertension. 2014;11(4):37-42. (In Russ.)

15. Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104-13. doi:10.1161/CIRCULATIONAHA.114.014310.

16. Postley JE, Perez A, Wong ND, et al. Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in low and intermediate risk adults: the New York physicians study. J Am Soc Echocardiogr. 2009;22(10):1145-51. doi:10.1016/j.echo.2009.07.010.


Supplementary files

Review

For citations:


Ershova A.I., Balakhonova T.V., Meshkov A.N., Kutsenko V.A., Yarovaya E.B., Shalnova S.A., Lishchenko N.E., Novikova A.S., Aleksandrova E.L., Shutemova E.A., Belova O.A., Rachkova S.A., Boytsov S.A., Drapkina O.M. Prevalence of carotid and femoral artery atherosclerosis among the Ivanovo Oblast population: data from the ATEROGEN-Ivanovo study. Cardiovascular Therapy and Prevention. 2021;20(5):2994. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2994

Views: 1991


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)